NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy Advocacy Hub | UniteRare

Regulatory Watchboard

No FDA or trial events recorded yet for NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance2

MYQORZO

Bristol Myers Squibb

OpenContact for detailsApply ↗

Ablysinol

Belcher Pharmaceuticals, LLC

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Ablysinol

(dehydrated alcohol)Orphan drug

Belcher Pharmaceuticals, LLC

12.1 Mechanism of Action Dehydrated alcohol is a tissue toxin that produces a myocardial infarction when injected through an intra-arterial catheter i...

Approved Jun 2018FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy.
Search all trials →

Search clinical trials for NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy →

Recent News & Research

No recent news articles indexed yet for NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy.
Search PubMed for NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy →

Browse all NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy news →

Specialist Network

No specialists currently listed for NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy.

View all NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰